{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:48:48Z","timestamp":1793296128094,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00108-022-01331-x","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T09:03:02Z","timestamp":1666342982000},"page":"619-630","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Gerinnungsdiagnostik im klinischen Alltag \u2013 Teil\u00a01","Coagulation diagnostics in the clinical routine\u2014Part\u00a01"],"prefix":"10.1007","volume":"63","author":[{"given":"Michael","family":"Metze","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Platz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Pfrepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirak","family":"Petros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"1331_CR1","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1126\/science.145.3638.1310","volume":"145","author":"EW Davie","year":"1964","unstructured":"Davie\u00a0EW, Ratnoff\u00a0OD (1964) Waterfall sequence for intrinsic blood clotting. Science 145:1310\u20131312","journal-title":"Science"},{"key":"1331_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1161\/01.ATV.0000193624.28251.83","volume":"26","author":"DM Monroe","year":"2006","unstructured":"Monroe\u00a0DM, Hoffman\u00a0M (2006) What does it take to make the perfect clot? Arterioscler Thromb Vasc Biol 26:41\u201348","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1331_CR3","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJMra0801082","volume":"359","author":"B Furie","year":"2008","unstructured":"Furie\u00a0B, Furie\u00a0BC (2008) Mechanisms of thrombus formation. N\u00a0Engl J Med 359:938\u2013949","journal-title":"N Engl J Med"},{"key":"1331_CR4","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","volume":"108","author":"N Mackman","year":"2009","unstructured":"Mackman\u00a0N (2009) The role of tissue factor and factor VIIa in hemostasis. Anesth Analg 108:1447\u20131452","journal-title":"Anesth Analg"},{"key":"1331_CR5","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/blood-2016-04-713289","volume":"128","author":"SW Pipe","year":"2016","unstructured":"Pipe\u00a0SW, Montgomery\u00a0RR, Pratt\u00a0KP et al (2016) Life in the shadow of a\u00a0dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A. Blood 128:2007\u20132016","journal-title":"Blood"},{"key":"1331_CR6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1378\/chest.106.3.661","volume":"106","author":"CS Kitchens","year":"1994","unstructured":"Kitchens\u00a0CS (1994) Preoperative PTs, PTTs, cost-effectiveness, and health care reform. Radical changes that make good sense. Chest 106:661\u2013662","journal-title":"Chest"},{"key":"1331_CR7","volume-title":"WHO guidelines on drawing blood: best practices in phlebotomy Geneva","author":"WH Organization","year":"2010","unstructured":"Organization\u00a0WH (2010) WHO guidelines on drawing blood: best practices in phlebotomy Geneva"},{"key":"1331_CR8","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3109\/09537100903236462","volume":"20","author":"D Bolliger","year":"2009","unstructured":"Bolliger\u00a0D, Seeberger\u00a0MD, Tanaka\u00a0KA et al (2009) Pre-analytical effects of pneumatic tube transport on impedance platelet aggregometry. Platelets 20:458\u2013465","journal-title":"Platelets"},{"key":"1331_CR9","first-page":"637","volume":"41","author":"RD Langdell","year":"1953","unstructured":"Langdell\u00a0RD, Wagner\u00a0RH, Brinkhous\u00a0KM (1953) Effect of antihemophilic factor on one-stage clotting tests; a\u00a0presumptive test for hemophilia and a\u00a0simple one-stage antihemophilic factor assy procedure. J\u00a0Lab Clin Med 41:637\u2013647","journal-title":"J Lab Clin Med"},{"key":"1331_CR10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00000441-193510000-00009","volume":"190","author":"AJ Quick","year":"1935","unstructured":"Quick\u00a0AJ, Stanley-Brown\u00a0M, Bancroft\u00a0F (1935) A study of the coagulation defect in hemophilia and in jaundice. Am J Med Sci 190:501\u2013511","journal-title":"Am J Med Sci"},{"key":"1331_CR11","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1111\/j.1538-7836.2005.01552.x","volume":"3","author":"CS Kitchens","year":"2005","unstructured":"Kitchens\u00a0CS (2005) To bleed or not to bleed? Is that the question for the PTT? J\u00a0Thromb Haemost 3:2607\u20132611","journal-title":"J Thromb Haemost"},{"key":"1331_CR12","first-page":"239","volume":"101","author":"AJ Quick","year":"1969","unstructured":"Quick\u00a0AJ (1969) Preoperative bleeding and clotting time. Can Med Assoc\u00a0J 101:239","journal-title":"Can Med Assoc J"},{"key":"1331_CR13","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1046\/j.1538-7836.2003.00298.x","volume":"1","author":"KG Mann","year":"2003","unstructured":"Mann\u00a0KG, Brummel\u00a0K, Butenas\u00a0S (2003) What is all that thrombin for? J\u00a0Thromb Haemost 1:1504\u20131514","journal-title":"J Thromb Haemost"},{"key":"1331_CR14","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/ajcp\/100.2.94","volume":"100","author":"ER Burns","year":"1993","unstructured":"Burns\u00a0ER, Goldberg\u00a0SN, Wenz\u00a0B (1993) Paradoxic effect of multiple mild coagulation factor deficiencies on the prothrombin time and activated partial thromboplastin time. Am J Clin Pathol 100:94\u201398","journal-title":"Am J Clin Pathol"},{"key":"1331_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1046\/j.1537-2995.1999.39199116895.x","volume":"39","author":"D Murray","year":"1999","unstructured":"Murray\u00a0D, Pennell\u00a0B, Olson\u00a0J (1999) Variability of prothrombin time and activated partial thromboplastin time in the diagnosis of increased surgical bleeding. Transfusion 39:56\u201362","journal-title":"Transfusion"},{"key":"1331_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","volume":"5","author":"PD James","year":"2021","unstructured":"James\u00a0PD, Connell\u00a0NT, Ameer\u00a0B et\u00a0al (2021) ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease. Blood Adv 5:280\u2013300","journal-title":"Blood Adv"},{"key":"1331_CR17","series-title":"AVWM S2K. Registernummer 086-003","volume-title":"Diagnose von Thrombozytenfunktionsst\u00f6rungen\u2014Thrombozytopathien","author":"R Kn\u00f6fler","year":"2018","unstructured":"Kn\u00f6fler\u00a0R (2018) Diagnose von Thrombozytenfunktionsst\u00f6rungen\u2014Thrombozytopathien. AVWM S2K. Registernummer 086-003"},{"key":"1331_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1080\/09537100601100366","volume":"18","author":"R Karger","year":"2007","unstructured":"Karger\u00a0R, Donner-Banzhoff\u00a0N, Muller\u00a0HH et al (2007) Diagnostic performance of the platelet function analyzer (PFA-100) for the detection of disorders of primary haemostasis in patients with a\u00a0bleeding history\u2014a systematic review and meta-analysis. Platelets 18:249\u2013260","journal-title":"Platelets"},{"key":"1331_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2141.2005.05511.x","volume":"130","author":"P Harrison","year":"2005","unstructured":"Harrison\u00a0P (2005) The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 130:3\u201310","journal-title":"Br J Haematol"},{"key":"1331_CR20","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/rth2.12339","volume":"4","author":"C Elbaz","year":"2020","unstructured":"Elbaz\u00a0C, Sholzberg\u00a0M (2020) An illustrated review of bleeding assessment tools and common coagulation tests. Res Pract Thromb Haemost 4:761\u2013773","journal-title":"Res Pract Thromb Haemost"},{"key":"1331_CR21","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1001\/jama.1985.03350480084025","volume":"253","author":"EB Kaplan","year":"1985","unstructured":"Kaplan\u00a0EB, Sheiner\u00a0LB, Boeckmann\u00a0AJ et\u00a0al (1985) The usefulness of preoperative laboratory screening. JAMA 253:3576\u20133581","journal-title":"JAMA"},{"key":"1331_CR22","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cll.2014.06.005","volume":"34","author":"JH Levy","year":"2014","unstructured":"Levy\u00a0JH, Szlam\u00a0F, Wolberg\u00a0AS et\u00a0al (2014) Clinical use of the activated partial thromboplastin time and prothrombin time for screening: a\u00a0review of the literature and current guidelines for testing. Clin Lab Med 34:453\u2013477","journal-title":"Clin Lab Med"},{"key":"1331_CR23","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/107602960401000301","volume":"10","author":"J Koscielny","year":"2004","unstructured":"Koscielny\u00a0J, Ziemer\u00a0S, Radtke\u00a0H et\u00a0al (2004) A practical concept for preoperative identification of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10:195\u2013204","journal-title":"Clin Appl Thromb Hemost"},{"key":"1331_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/107602960401000206","volume":"10","author":"J Koscielny","year":"2004","unstructured":"Koscielny\u00a0J, von Tempelhoff\u00a0GF, Ziemer\u00a0S et\u00a0al (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10:155\u2013166","journal-title":"Clin Appl Thromb Hemost"},{"key":"1331_CR25","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00101-017-0321-5","volume":"66","author":"Deutsche Gesellschaft fur Anasthesiologie und I","year":"2017","unstructured":"Deutsche Gesellschaft fur Anasthesiologie und I, Deutsche Gesellschaft fur Innere M, Deutsche Gesellschaft fur C et\u00a0al (2017) Preoperative evaluation of adult patients before elective, noncardiothoracic surgery : Joint recommendation of the German Society of Anesthesiology and Intensive Care Medicine, the German Society of Surgery, and the German Society of Internal Medicine. Anaesthesist 66:442\u2013458","journal-title":"Anaesthesist"},{"key":"1331_CR26","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1007\/s00101-007-1182-0","volume":"56","author":"G Pfanner","year":"2007","unstructured":"Pfanner\u00a0G, Koscielny\u00a0J, Pernerstorfer\u00a0T et\u00a0al (2007) Preoperative evaluation of the bleeding history. Recommendations of the working group on perioperative coagulation of the Austrian Society for Anaesthesia, Resuscitation and Intensive Care. Anaesthesist 56:604\u2013611","journal-title":"Anaesthesist"},{"key":"1331_CR27","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00228-019-02646-9","volume":"75","author":"C Pfrepper","year":"2019","unstructured":"Pfrepper\u00a0C, Deters\u00a0S, Metze\u00a0M et al (2019) Metamizole inhibits arachidonic acid-induced platelet aggregation after surgery and impairs the effect of aspirin in hospitalized patients. Eur J Clin Pharmacol 75:777\u2013784","journal-title":"Eur J Clin Pharmacol"},{"key":"1331_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MBC.0b013e328343f7be","volume":"22","author":"S Lison","year":"2011","unstructured":"Lison\u00a0S, Weiss\u00a0G, Spannagl\u00a0M et\u00a0al (2011) Postoperative changes in procoagulant factors after major surgery. Blood Coagul Fibrinolysis 22:190\u2013196","journal-title":"Blood Coagul Fibrinolysis"},{"key":"1331_CR29","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1055\/s-2003-38329","volume":"3","author":"P Clark","year":"2003","unstructured":"Clark\u00a0P (2003) Changes of hemostasis variables during pregnancy. Semin Vasc Med 3:13\u201324","journal-title":"Semin Vasc Med"},{"key":"1331_CR30","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1055\/s-0038-1646899","volume":"62","author":"C Jern","year":"1989","unstructured":"Jern\u00a0C, Eriksson\u00a0E, Tengborn\u00a0L et\u00a0al (1989) Changes of plasma coagulation and fibrinolysis in response to mental stress. Thromb Haemost 62:767\u2013771","journal-title":"Thromb Haemost"},{"key":"1331_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1477-9560-5-14","volume":"5","author":"M Franchini","year":"2007","unstructured":"Franchini\u00a0M, Capra\u00a0F, Targher\u00a0G et\u00a0al (2007) Relationship between ABO blood group and von Willebrand factor levels: from biology to clinical implications. Thromb\u00a0J 5:14","journal-title":"Thromb J"},{"key":"1331_CR32","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.transci.2018.10.013","volume":"57","author":"MTS Yan","year":"2018","unstructured":"Yan\u00a0MTS, Rydz\u00a0N, Goodyear\u00a0D et\u00a0al (2018) Acquired factor XIII deficiency: a review. Transfus Apher Sci 57:724\u2013730","journal-title":"Transfus Apher Sci"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-022-01331-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-022-01331-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T14:13:33Z","timestamp":1668608013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-022-01331-x"}},"subtitle":["Evaluation des Blutungsrisikos vor Operationen, Interventionen und Diagnostik bei Blutungsneigung","Evaluation of the risk of bleeding before surgery, interventions and diagnostics in bleeding diathesis"],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1331"],"URL":"https:\/\/doi.org\/10.1007\/s00108-022-01331-x","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"4 April 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>M. Metze<\/b>: A. Finanzielle Interessen: Forschungsf\u00f6rderung: Daiichi Sankyo. \u2013\u00a0Referentenhonorar: Bayer, Pfizer.\u00a0\u2013 Berater: Bayer, Boehringer Ingelheim, Daiichi Sankyo. \u2013\u00a0B. Nichtfinanzielle Interessen: Angestellter Kardiologe und H\u00e4mostaseologe, Universit\u00e4tsklinikum Leipzig | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Kardiologie \u2013 Herz- und Kreislaufforschung (DGK), Gesellschaft f\u00fcr Thrombose- und H\u00e4mostaseforschung (GTH), International Society on Thrombosis and Haemostasis (ISTH). <b>M. Platz<\/b>: A. Finanzielle Interessen: M. Platz gibt an, dass kein finanzieller Interessenkonflikt besteht.\u00a0\u2013 B. Nichtfinanzielle Interessen: Facharzt, Klinik und Poliklinik f\u00fcr Kardiologie, Universit\u00e4tsklinikum Leipzig | Mitgliedschaften: Berufsverband Deutscher Internistinnen und Internisten (BDI), Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), DGK, European Society of Cardiology (ESC), Marburger Bund. <b>S. Petros<\/b>: A. Finanzielle Interessen: Forschungsf\u00f6rderung: Bayer Vital, CSL Behring, Stago, Werfen. \u2013\u00a0Vortragshonorar: Bristol Myers Squibb, Boehringer Ingelheim, CSL Behring, MSD, Novo Nordisk, Portola, Sanofi, Sch\u00f6chl Medical.\u00a0\u2013 B. Nichtfinanzielle Interessen: Leiter der Interdisziplin\u00e4ren Internistischen Intensivmedizin, Universit\u00e4tsklinikum Leipzig, Leiter des Bereichs H\u00e4mostaseologie, Universit\u00e4tsklinikum Leipzig | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Innere Medizin (DGIM), Deutsche Gesellschaft f\u00fcr Internistische Intensivmedizin und Notfallmedizin (DGIIN), Deutsche Interdisziplin\u00e4re Vereinigung f\u00fcr Intensiv- und Notfallmedizin (DIVI), GTH, European Society of Intensive Care Medicine (ESICM), ISTH. <b>C.\u00a0Pfrepper<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar: Bayer, Pfizer \u2013\u00a0Berater: Pfizer)\u00a0\u2013 Forschungsf\u00f6rderung: Leo Pharma, Roche\/Chugai, Zacros - B. Nichtfinanzielle Interessen: Angestellter H\u00e4mostaseologe, Universit\u00e4tsklinikum Leipzig | Mitgliedschaften: GTH, ISTH.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}